We evaluated 3 diagnostic samples, including ALL with KMT2A::MLLT10 (SJALL016500), AML with PICALM::MLLT10 (SJAML030459), and AML with NUP98::NSD1 (SJAML001441). This evidence concerns the gene NSD1 and acute lymphoblastic leukemia.